We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Embryonic Stem Cells From Adult Cells

By Biotechdaily staff writers
Posted on 31 Aug 2005
Scientists have created a new type of hybrid cell by fusing adult cells with embryonic stem cells in such a way that the embryonic cells reset the genetic clock of the adult cells, turning them back to their embryonic form. More...
When this feat is fully understood, it may lead to genetically tailored treatments for diseases without the need to create or destroy human embryos.

The adult cells used in the experiment came from foreskin and pelvic areas. In their embryonic form, it may be possible to coax them back "into replacement cells and even organs,” said lead author Chad Cowan, a biologist at the Harvard Stem Cell Institute (Boston, MA, USA). For example, normal cells might be made to replace abnormal ones that cause juvenile diabetes or Alzheimer's disease.

The next step is to figure out how an embryonic cell can turn back, or reprogram, the genes of an adult cell. That could take 10 years, suggests Dr. Cowan. In the meantime, research on the use of hybrid cells for helping patients can continue. The quickest way to new treatments is finding a way to remove the embryonic DNA. "That's the primary hurdle in the foot race to find treatments for patients,” observed Kevin Eggan, also of the Harvard Stem Cell Institute.

When all the problems are solved, the Harvard team sees a new source of stem cells produced without the need to create or destroy embryos that some people insist are "alive.” "We will never satisfy all of the ethical objections to using embryonic stem cells,” admits Dr. Cowan, "but we believe that the majority of people will find this technique morally acceptable.” A report on the research was published in the August 26, 2005, issue of Science.




Related Links:
Harvard U.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.